| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| D13.6 | Benign neoplasm of pancreas |
| D61.810 | Antineoplastic chemotherapy induced pancytopenia |
| D64.81 | Anemia due to antineoplastic chemotherapy |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
| P04.11 | Newborn affected by maternal antineoplastic chemotherapy |
| T80.810 | Extravasation of vesicant antineoplastic chemotherapy |
| T80.810A | Extravasation of vesicant antineoplastic chemotherapy, initial encounter |
| T80.810D | Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter |
| T80.810S | Extravasation of vesicant antineoplastic chemotherapy, sequela |
| Z51.1 | Encounter for antineoplastic chemotherapy and immunotherapy |
| Z51.11 | Encounter for antineoplastic chemotherapy |
| Z79.5 | Long term (current) use of steroids |
| Z79.8 | Other long term (current) drug therapy |
| Z79.89 | Other long term (current) drug therapy |
| Z79.891 | Long term (current) use of opiate analgesic |
| Z79.899 | Other long term (current) drug therapy |
| Z85.0 | Personal history of malignant neoplasm of digestive organs |
| Z85.00 | Personal history of malignant neoplasm of unspecified digestive organ |
| Z85.05 | Personal history of malignant neoplasm of liver |
| Z85.07 | Personal history of malignant neoplasm of pancreas |
| Z92.21 | Personal history of antineoplastic chemotherapy |